Premium
Reversal of multi‐drug resistance in human KB cell lines by structural analogs of verapamil
Author(s) -
Pirker Robert,
Keilhauer Gerhard,
Raschack Manfred,
Lechner Christina,
Ludwig Heinz
Publication year - 1990
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910450523
Subject(s) - verapamil , drug , drug resistance , pharmacology , cell culture , medicine , biology , genetics , calcium
Several structural analogs of verapamil were studied for their ability to reverse multi‐drug resistance (MDR) in human KB cell lines. D595, D792 and verapamil completely reversed resistance to colchicine and adriamycin. D595 and D792 had a higher reversing potency than verapamil. Devapamil, gallopamil, emopamil and D528 partially reversed MDR. The reversing potency of a drug did not correlate with its calcium antagonistic activity. No differences in reversing potency between (R)‐isomers, (L)‐isomers and the racemic forms were observed in the case of both verapamil and emopamil. (R)‐verapamil, which has less calcium antagonistic activity and less in vivo toxicity than racemic verapamil, and D792, which has higher reversing potency and less in vivo toxicity than racemic verapamil, should be suitable for clinical applications to overcome drug resistance in cancer patients.